(Q50669860)

17 March 2018

title

Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis. (English)

1 reference

17 March 2018

1 reference

1 reference

Hitsumoto T

1

1 reference

17 March 2018

Ohsawa H

2

1 reference

17 March 2018

Uchi T

3

1 reference

17 March 2018

Noike H

4

1 reference

17 March 2018

Kanai M

5

1 reference

17 March 2018

Yoshinuma M

6

1 reference

17 March 2018

Miyashita Y

7

1 reference

17 March 2018

Watanabe H

8

1 reference

17 March 2018

Shirai K

9

1 reference

17 March 2018

publication date

1 December 2000

1 reference

17 March 2018

published in

Atherosclerosis

1 reference

17 March 2018

volume

153

1 reference

17 March 2018

issue

2

1 reference

17 March 2018

page(s)

391-396

1 reference

17 March 2018

Lipolytic enzymes and plasma lipoprotein metabolism

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Regulation of the synthesis, processing and translocation of lipoprotein lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Transport of lipoprotein lipase across endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Preheparin serum lipoprotein lipase mass level: the effects of age, gender, and types of hyperlipidemias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

The effect of insulin sensitizer, troglitazone, on lipoprotein lipase mass in preheparin serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Lipoprotein lipase mass and activity in severe hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Selective coronary arteriography. I. A percutaneous transfemoral technic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Clinical efficacy of the direct assay method using polymers for serum high density lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900413-5

10.1016/S0021-9150(00)00413-5

7 January 2021

Identifiers

DOI

1 reference

17 March 2018

release_qbxezroz7fba3ai6543nzjtwdu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qbxezroz7fba3ai6543nzjtwdu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

17 March 2018